FTC Settles With Amgen Over $27.8 Billion Deal for Horizon Therapeutics
The Federal Trade Commission reached a settlement with Amgen that would allow the drugmaker to acquire Horizon Therapeutics and dismisses the antitrust claims of six states. #press